June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Demodex Blepharitis and Coexisting Bacterial Burden in Eye Care Patients: The Pandora Study
Author Affiliations & Notes
  • Kiersten Snyder
    Ophthalmology, New York Medical College, Valhalla, New York, United States
  • Francis Mah
    Cornea Service, Scripps Health, San Diego, California, United States
  • Alanna Nattis
    New York Institute of Technology College of Osteopathic Medicine, Old Westbury, New York, United States
    SightMD, New York, United States
  • Eric Rosenberg
    New York Medical College, Valhalla, New York, United States
    SightMD, New York, United States
  • Elizabeth Yeu
    Virginia Eye Consultants, Virginia, United States
  • Footnotes
    Commercial Relationships   Kiersten Snyder None; Francis Mah Tarsus, Code C (Consultant/Contractor); Alanna Nattis Tarsus, Code C (Consultant/Contractor); Eric Rosenberg Tarsus, Code C (Consultant/Contractor); Elizabeth Yeu Tarsus, Code C (Consultant/Contractor)
  • Footnotes
    Support  Tarsus
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3952 – A0232. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kiersten Snyder, Francis Mah, Alanna Nattis, Eric Rosenberg, Elizabeth Yeu; Demodex Blepharitis and Coexisting Bacterial Burden in Eye Care Patients: The Pandora Study. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3952 – A0232.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Demodex is a vector for bacteria and the prevalence of bacteria on eyelids has shown to be correlated with Demodex presence. To understand type(s) and/or number of bacteria in those with Demodex blepharitis, the Pandora study evaluated the bacterial flora on the eyelid margin and conjunctival fornices in Demodex blepharitis (DB) and normal or non-Demodex blepharitis (non-DB) patients.

Methods : This is a prospective, observational, multicenter study. Swabs were taken from the eyelid margin and conjunctival fornices of 24 patients with at least 10 collarettes (DB) and 11 patients who have no diagnosis of DB or other forms of blepharitis (patients without collarettes, or signs or symptoms consistent with blepharitis). By study completion, samples from a total of 60 DB patients and at least 40 non-DB patients will be collected. All eyelid/conjunctival swabs were sent for culture on blood, Chocolate and Sabouraud agar plates and gram stain.

Results : Methicillin-resistant Staphylococcus epidermidis (MRSE) were isolated from 29% (7/24) of DB patients while only 2 out of 11 patients (18%) had MRSE in the non-DB group. More than one type of bacteria was found in 63% and 45% of the DB and non-DB patients, respectively. Staphylococcus epidermidis was the most isolated bacteria in both DB and non-DB eyelids but methicillin-sensitive coagulase negative Staphylococcus epidermidis was more commonly isolated in non-DB patients (45% vs 21%).

Conclusions : These preliminary results suggest that more pathogenic (MRSE) and more bacterial strains are found in DB patients compared to normal patients. This signifies the importance of treating Demodex blepharitis to minimize the presence of pathogenic bacteria which can compromise outcomes in patients wearing contact lenses or undergoing refractive or cataract surgery. Larger sample size upon study completion will confirm these preliminary findings.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×